Clinical trials

Filters
Clear filters
1,718 trials
TrialSponsorPhaseStatusPrimary completion
Cough Reduction in IPF With Nalbuphine ERNCT05964335Trevi TherapeuticsPhase 2Completed2025-04-24Actual
Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus ErythematosusNCT05966480ALMSPhase 2Active not recruiting2026-06-23Actual
A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCEDNCT05966493Glaukos CorporationPhase 2Recruiting2025-12Estimated
Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With HypertensionNCT05968430MLYSPhase 3Active not recruiting2025-12-30Actual
A Study to Assess the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS)NCT05972044AXSMPhase 3Completed2025-02-07Actual
Safety and Efficacy of OMS906 in Paroxysmal Nocturnal Hemoglobinuria Patients With a Sub-optimal Response to RavulizumabNCT05972967Omeros CorporationPhase 2Completed2024-10-10Actual
Phase 3 Adolescent Study for SARS-CoV-2 rS Variant VaccinesNCT05973006NovavaxPhase 3Completed2024-04-01Actual
A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.NCT05975060NovavaxPhase 2, Phase 3Completed2023-11-15Actual
A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study).NCT05975905KROSPhase 2Terminated2025-03-05Actual
A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate ThrombocytopeniaNCT05980806KPTIPhase 2Recruiting2027-06Estimated
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEFNCT05983250TENXPhase 3Active not recruiting2026-06-30Actual
Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney TransplantationNCT05983770Eledon PharmaceuticalsPhase 2Completed2025-09-11Actual
IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal MelanomaNCT05987332IDEAYA BiosciencesPhase 2, Phase 3Active not recruiting2027-01-15Estimated
IMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH)NCT05989711ALTPhase 2Completed2025-11-25Actual
Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAHNCT05995405GRCEPhase 3Active not recruiting2024-12Estimated
A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the KneeNCT06000410OrganogenesisPhase 3Completed2025-08-15Actual
A Study of REC-4881 in Participants With Cancers Which Have an AXIN1 or APC MutationNCT06005974RXRXPhase 2Terminated2025-02-24Actual
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal MelanomaNCT06007690Aura BiosciencesPhase 3Active not recruiting2027-11-15Estimated
A Study to Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson's DiseaseNCT06015841ACIUPhase 2Active not recruiting2028-06Estimated
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast CancerNCT06016738OLMAPhase 3Active not recruiting2026-10-31Estimated
A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)NCT06018428QTTBPhase 2Active not recruiting2026-06Estimated
A 2nd Generation E1/E2B/E3-Deleted Adenoviral COVID-19 Vaccine: The TCELL VACCINE TRIALNCT06022224IBRXPhase 2, Phase 3Terminated2022-06-23Actual
Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive DisorderNCT06029426NMRAPhase 3Completed2024-12-03Actual
Study to Assess the Safety and Effectiveness of NMRA-335140-501NCT06029439NMRAPhase 3Terminated2026-08-17Actual
Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects With Polycythemia VeraNCT06033586PTGXPhase 3Active not recruiting2026-04-01Estimated
Descartes-08 for Patients With Systemic Lupus ErythematosusNCT06038474Cartesian TherapeuticsPhase 2Active not recruiting2026-12-01Estimated
A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2NCT06039449IVVDPhase 3Completed2024-11-19Actual
A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR)NCT06041269ANABPhase 2Active not recruiting2024-11-29Estimated
Comparing Efficacy & Safety Of TNX-1300 To Placebo With UC For Treatment Of Acute Cocaine Intoxication In ED Subjects (CATALYST)NCT06045793Tonix Pharmaceuticals, Inc.Phase 2Terminated2025-04-21Actual
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic ObesityNCT06046443RYTMPhase 2Completed2026-02-09Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.